Syros Pharmaceuticals Inc (OQ:SYRS)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
BioMarin Pharmaceutical (OQ:BMRN)
Allakos (OQ:ALLK)
Latest 10 SEC filings (by transaction date) for SYRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 11/19 Apr 9/19 Akkaraju Srinivas Indirect Ownership Common Stock Warrants (rights to buy) P - Open market or private purchase 133,333  
Apr 11/19 Apr 9/19 Akkaraju Srinivas Indirect Ownership Common Stock P - Open market or private purchase 533,332 $7.50
Mar 14/19 Mar 14/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -43,000 $8.15
Mar 14/19 Mar 13/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -2,820 $8.20
Mar 14/19 Mar 13/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -81,591 $7.89
Mar 14/19 Mar 12/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -40,092 $7.37
Mar 11/19 Mar 11/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -44,878 $6.49
Mar 11/19 Mar 8/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -84,496 $6.93
Mar 11/19 Mar 7/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -35,209 $6.87
Feb 14/19 Feb 12/19 Springhorn Jeremy P. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 75,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SYRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 11/19 Apr 9/19 Akkaraju Srinivas Indirect Ownership Common Stock Warrants (rights to buy) P - Open market or private purchase 133,333  
Apr 11/19 Apr 9/19 Akkaraju Srinivas Indirect Ownership Common Stock P - Open market or private purchase 533,332 $7.50
Mar 14/19 Mar 14/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -43,000 $8.15
Mar 14/19 Mar 13/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -2,820 $8.20
Mar 14/19 Mar 13/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -81,591 $7.89
Mar 14/19 Mar 12/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -40,092 $7.37
Mar 11/19 Mar 11/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -44,878 $6.49
Mar 11/19 Mar 8/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -84,496 $6.93
Mar 11/19 Mar 7/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -35,209 $6.87
Feb 14/19 Feb 12/19 Springhorn Jeremy P. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 75,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $SYRS

StockTwits